Dermatomyositis as presenting feature of ovarian cancer, treated with neo-adjuvant chemotherapy and interval debulking surgery()

• Dermatomyositis in ovarian cancer responds to treatment with neo-adjuvant carboplatin and paclitaxel in conjunction with corticosteroids. • Recurrence of dermatomyositis symptoms is often the first sign of relapsed disease. • Prognosis of ovarian cancer in context of dermatomyositis is poor.

Detalles Bibliográficos
Autores principales: Christie, Alan, McKay, Neil, Nussey, Fiona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862295/
https://www.ncbi.nlm.nih.gov/pubmed/24371708
http://dx.doi.org/10.1016/j.gynor.2013.07.002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3862295/
https://www.ncbi.nlm.nih.gov/pubmed/24371708
http://dx.doi.org/10.1016/j.gynor.2013.07.002

Ejemplares similares